Clinical pharmacological components, including Regorafenib, are discontinued on an acceptable pharmaceutical vehicle； manufacturing procedures and their use for the treatment or prevention of eye disorders.

• 收藏
• 分享

专利权人:

BAYER HEALTHCARE LLC.

发明人:

KLAR, JÜRGEN,BÖTTHER, MICHAEL,VON DE DEGENFELD, GEORGES,FREUNDLIEB, JULIA,HIRTH-DIETRICH, CLAUDIA,KELDENICH, JOERG,MUENSTER, UWE,OHM, ANDREAS,RICHTER, ANNETT,RIEDL, BERND

申请号：

CL2013003700

公开号：

CL2013003700A1

申请日:

2013.12.23

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

The present invention relates to topical ophthalmological pharmaceutical compositions containing regorafenib, a hydrate, solvate or pharmaceutically acceptable salt thereof or a polymorph thereof and its process of preparation and its use for treating ophthalmological disorders.COMPOSICION FARMACEUTICA OFTALMOLOGICA TOPICA QUE COMPRENDE REGORAFENIB, EL CUAL SE ENCUENTRA SUSPENDIDO EN UN VEHICULO FARMACEUTICAMENTE ACEPTABLE； PROCEDIMIENTO DE FABRICACION Y SU USO PARA TRATAR O PREVENIR UN TRASTORNO OFTALMOLOGICO.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/